Literature DB >> 542241

Reoperations in strabismus.

E M Helveston.   

Abstract

Reoperations in strabismus are done for overcorrection, undercorrections, and new strabismus problems such as dissociated vertical deviation and ptosis. Each patient requiring reoperation should be thoroughly evaluated on the basis of current findings with the understanding that some alteration in anatomy will be found. Restrictions must be freed and muscle force balanced to first provide straight eyes in the primary position and secondly the best vision possible. With persistence, 80% to 90% of patients requiring reoperation can expect a satisfactory end result.

Entities:  

Mesh:

Year:  1979        PMID: 542241     DOI: 10.1016/s0161-6420(79)37007-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Amniotic membrane in the management of strabismus reoperations.

Authors:  Betul Tugcu; Firat Helvacioglu; Erdal Yuzbasioglu; Ceren Gurez; Ulviye Yigit
Journal:  Jpn J Ophthalmol       Date:  2012-12-13       Impact factor: 2.447

2.  Early retreatment of infantile esotropia: comparison of reoperation and botulinum toxin.

Authors:  J Tejedor; J M Rodríguez
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

3.  Retreatment of children after surgery for acquired esotropia: reoperation versus botulinum injection.

Authors:  J Tejedor; J M Rodríguez
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

4.  Bilateral Medial Rectus Advancement versus Unilateral Medial Rectus Advancement with Lateral Rectus Recession for Surgical Management of Large Angle Consecutive Exotropia without Adduction Deficit.

Authors:  Sahar Torky Abdelrazik Abdelaziz; Mohamed Farag Khalil Ibrahiem
Journal:  Clin Ophthalmol       Date:  2022-08-16

5.  Commentary: Reoperation following strabismus surgery among Medicare beneficiaries: Associations with geographic region, academic affiliation, surgeon volume, and adjustable suture technique - Operations again! What lessons do we gain?

Authors:  Pradeep Sharma; Nripen Gaur
Journal:  Indian J Ophthalmol       Date:  2018-08       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.